Laxoberal (Sodium Picosulfate)

• Laxoberal, a stimulant laxative, acts on the lower gastrointestinal tract to promote bowel movements in several clinical situations.
• Constipation: provides relief by stimulating colonic peristalsis in patients with functional or opioid‑induced constipation.
• Bowel cleansing prior to diagnostic procedures: facilitates rapid evacuation of the colon before colonoscopy, sigmoidoscopy or radiologic imaging.

• Sodium picosulfate is a pro‑drug that is converted by colonic bacteria into its active metabolite, which stimulates enteric nerve endings. This activation increases fluid secretion into the intestinal lumen and enhances smooth‑muscle contraction, thereby accelerating colonic transit and promoting defecation.

Laxoberal may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Abdominal cramps or discomfort
• Diarrhea or loose stools
• Nausea or mild vomiting
• Flatulence or bloating
• Urgency to defecate
• Mild electrolyte imbalance (e.g., low potassium)

Serious or Rare Side Effects

• Severe dehydration
• Marked electrolyte disturbances (e.g., hyponatremia)
• Allergic reactions such as rash or angioedema
• Colonic perforation
• Persistent severe abdominal pain

Before prescribing Laxoberal, clinicians should consider several safety aspects.

• Assess bowel function: confirm presence of constipation and rule out obstruction.
• Avoid in acute abdominal pain or suspected mechanical blockage.
• Use with caution in patients with electrolyte disorders or renal impairment.
• Do not exceed recommended duration: prolonged use may cause dependence.
• Pediatric use: limit to children under medical supervision.
• Store at room temperature: keep in the original pack, protect from moisture.

Laxoberal can interact with other medications that affect gastrointestinal motility or electrolyte balance.

Major Interactions (Avoid)

• Concurrent use of other stimulant laxatives or high‑dose mineral oil.
• Loop or thiazide diuretics: risk of additive electrolyte loss.
• Cardiac glycosides: potential for arrhythmia due to potassium depletion.

Moderate Interactions (Monitor Closely)

• NSAIDs: increased risk of gastrointestinal irritation.
• Antidepressants (e.g., SSRIs): may enhance serotonergic effects on gut motility.
• Oral rehydration solutions: monitor electrolyte status when used together.